Epilepsy Trial, Recruiting NCT03644732 Sponsor: University Hospital, Grenoble Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT03644732
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have focal epilepsy that has not responded well to medication
  • People who are already scheduled for a specific type of brain monitoring procedure (called SEEG) as part of planning for possible epilepsy surgery
  • People who have provided written agreement that they do not object to taking part in the study
  • People who have the mental and cognitive ability to participate in thinking and memory tasks as part of the study

Who may not be able to join:

  • People who are under a legal protection order, or whose freedom is restricted by a court or government decision
  • People for whom it is not possible to gather background information, for example due to having recently arrived in France or a language barrier
  • People who are pregnant, as the SEEG procedure is not considered safe during pregnancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philippe Kahane, MD/PhD, University Hospital, Grenoble

Phone: +33 476 765 488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
5 April 2018
Est. completion
1 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

SEEG recordings using functional brain mapping procedure (composite measures)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov